Advancements in human gene therapy depend to a large degree on the development of delivery systems capable of the efficient introduction of the genetic material into the target cell. The experiments proposed in this application are designed to evaluate the potential advantage of a new synthetic methodology, namely the genetic engineering of polymers (as gene carriers), of the complexation behavior of cationic copolymers of amino acids with DNA, and their corresponding transfection efficiency. Through sequence-specific design, this technology provides a unique means to synthesize biopolymers with sell defined properties such as charge periodicity, molecular weight, and three dimensional structure, and allows for the precise introduction of of informational peptide sequences along the polymeric backbone. The broad long-term objective of this research is to develop novel genetically engineered polymers for gene delivery.
The specific aims are: 1. To examine the effect of synthetic methodology on the alpha-helical content of a series of model cationic copolymers of arginine, lysine, serine, and alanine, and on polymer DNA complexation and transfection efficiency. Random copolymers will be compared with their genetically engineered counterparts. 2. To examine the effect of discrete molecular weight changes on polymer-DNA complexation and transfection efficiency. A series of monodisperse copolymers of lysine and serine with varying molecular weights will be genetically engineered and their complexation with DNA and transfection efficiency will be evaluated. 3. To examine the effect of charge density and charge periodicity; random copolymers of lysine, and alanine will be compared with genetically engineered counterparts. 4. To study the effect of location of GALA as a model membrane destabilizing agent along the polymer chain on transfection efficiency. Results from these studies may pave the way for new polymer-DNA constructs where with a high degreee of precision, it may be possible to tailor-make polymeric gene carriers with an improved transfection efficiency.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15GM061360-01
Application #
2883930
Study Section
Surgery and Bioengineering Study Section (SB)
Program Officer
Chin, Jean
Project Start
1999-08-01
Project End
2002-07-31
Budget Start
1999-08-01
Budget End
2002-07-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Nagarsekar, Ashish; Crissman, John; Crissman, Mary et al. (2002) Genetic synthesis and characterization of pH- and temperature-sensitive silk-elastinlike protein block copolymers. J Biomed Mater Res 62:195-203
Megeed, Zaki; Cappello, Joseph; Ghandehari, Hamidreza (2002) Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv Drug Deliv Rev 54:1075-91
Megeed, Zaki; Cappello, Joseph; Ghandehari, Hamidreza (2002) Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm Res 19:954-9